| Inhibitors of the JAK-STAT pathway can control various proinflammatory cytokines. |
| Baricitinib is increasingly being used to treat auto-inflammatory diseases. |
| Additional clinical studies are needed to confirm the therapeutic effect of baricitinib in adult-onset Still’s disease. |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.